Literature DB >> 15249413

The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.

Edward Lin1, Nana Gletsu, Kim Fugate, David McClusky, Li H Gu, Juan-Li Zhu, Bruce J Ramshaw, Dimitris A Papanicolaou, Thomas R Ziegler, C Daniel Smith.   

Abstract

HYPOTHESIS: Circulating ghrelin, produced primarily in the stomach, is a powerful orexigen. Ghrelin levels are elevated in states of hunger, but rapidly decline postprandially. Early alterations in ghrelin levels in morbidly obese patients undergoing weight reduction surgery may be attributed to gastric partitioning. DESIGN AND PATIENTS: Thirty-four patients underwent Roux-en-Y gastric bypass with a completely divided gastroplasty to create a 15-mL vertically oriented gastric pouch. Eight other patients underwent other gastric procedures that did not involve complete division of the stomach, including 4 vertical banded gastroplasties and 4 antireflux surgical procedures. Six additional patients undergoing antireflux surgery served as lean control subjects. Plasma samples were obtained before surgery and immediately after surgery. In a substudy, plasma was collected after Roux-en-Y limb formation and after dividing the stomach to identify any changes in plasma ghrelin levels.
SETTING: Tertiary university medical center. MAIN OUTCOME MEASURES: Ghrelin levels at different stages of surgical intervention.
RESULTS: Mean +/- SEM preoperative and postoperative ghrelin levels in the gastric bypass group were 355 +/- 20 and 246 +/- 13 pg/mL, respectively (P<.001). In the vertical banded gastroplasty group and in all patients undergoing antireflux surgery, ghrelin levels were not significantly changed.
CONCLUSIONS: Compared with morbidly obese humans, lean controls had significantly higher plasma ghrelin levels at baseline. A divided gastroplasty creating a small proximal gastric pouch results in significant early declines in circulating ghrelin levels that are not observed with other gastric procedures. This may explain, in part, the loss of hunger sensation and rapid weight loss observed following gastric bypass surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249413     DOI: 10.1001/archsurg.139.7.780

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  44 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

Review 2.  Morbid obesity and sleeve gastrectomy: how does it work?

Authors:  Joanna Papailiou; Konstantinos Albanopoulos; Konstantinos G Toutouzas; Christos Tsigris; Nikolaos Nikiteas; George Zografos
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

Review 3.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 4.  Obesity, gut hormones, and bariatric surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss.

Authors:  J Ybarra; E Bobbioni-Harsch; G Chassot; O Huber; Ph Morel; F Assimacopoulos-Jeannet; A Golay
Journal:  Obes Surg       Date:  2008-10-31       Impact factor: 4.129

Review 6.  Hormonal regulation of gastric acid secretion.

Authors:  Mitchell L Schubert
Journal:  Curr Gastroenterol Rep       Date:  2008-12

7.  Revised sleeve gastrectomy: another option for weight loss failure after sleeve gastrectomy.

Authors:  Patrick Noel; Marius Nedelcu; David Nocca; Anne-Sophie Schneck; Jean Gugenheim; Antonio Iannelli; Michel Gagner
Journal:  Surg Endosc       Date:  2013-10-30       Impact factor: 4.584

8.  Does Weight Gain During the Operation Wait Time Have an Impact on Weight Loss After Laparoscopic Sleeve Gastrectomy?

Authors:  Haci Murat Cayci; Umut Eren Erdogdu; Kerem Karaman; Ersin Budak; İbrahim Taymur; Cagatay Buyukuysal
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

9.  Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.

Authors:  Alexander V Mayorov; Neri Amara; Jason Y Chang; Jason A Moss; Mark S Hixon; Diana I Ruiz; Michael M Meijler; Eric P Zorrilla; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

10.  Ghrelin and metabolic surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  Int J Pept       Date:  2010-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.